
1. malar j. 2015 jun 4;14:233. doi: 10.1186/s12936-015-0748-6.

development genetic tool functional screening anti-malarial bioactive
extracts metagenomic libraries.

mongui a(1)(2), pérez-llanos fj(3)(4), yamamoto mm(5), lozano m(6), zambrano
mm(7), del portillo p(8), fernández-becerra c(9), restrepo s(10), del portillo
ha(11)(12), junca h(13)(14).

author information: 
(1)rg microbial ecology: metabolism, genomics & evolution - corpogen, bogotá,
colombia. amonguic@gmail.com.
(2)department biological sciences, universidad de los andes, bogotá, colombia.
amonguic@gmail.com.
(3)rg microbial ecology: metabolism, genomics & evolution - corpogen, bogotá,
colombia. francisjpll@gmail.com.
(4)department biological sciences, universidad de los andes, bogotá, colombia.
francisjpll@gmail.com.
(5)departamento de parasitologia, universidade de são paulo, são paulo, brazil.
masayama@gmail.com.
(6)rg microbial ecology: metabolism, genomics & evolution - corpogen, bogotá,
colombia. macheperez@hotmail.com.
(7)rg microbial ecology: metabolism, genomics & evolution - corpogen, bogotá,
colombia. mzambrano@corpogen.org.
(8)rg microbial ecology: metabolism, genomics & evolution - corpogen, bogotá,
colombia. pdelportillo@corpogen.org.
(9)icrea isglobal, barcelona ctr int health res (cresib), hospital clínic -
universitat de barcelona, barcelona, spain. carmen.fernandez@cresib.cat.
(10)department biological sciences, universidad de los andes, bogotá,
colombia. srestrep@uniandes.edu.co.
(11)icrea isglobal, barcelona ctr int health res (cresib), hospital clínic -
universitat de barcelona, barcelona, spain. hernandoa.delportillo@cresib.cat.
(12)institució catalana de recerca estudis avançats (icrea), barcelona, spain. 
hernandoa.delportillo@cresib.cat.
(13)rg microbial ecology: metabolism, genomics & evolution - corpogen, bogotá,
colombia. info@howardjunca.com.
(14)present address: applied biology program, faculty basic & applied
sciences, universidad militar nueva granada-umng, campus cajicá, bogotá, dc,
colombia. info@howardjunca.com.

background: chemical treatment plasmodium falciparum human infections 
is losing efficacy year due rise resistance. one possible strategy
to find novel anti-malarial drugs access largest reservoir genomic
biodiversity source earth present metagenomes environmental microbial
communities.
methods: bioluminescent p. falciparum parasite used quickly detect
shifts viability microcultures grown 96-well plates. synthetic gene
encoding dermaseptin 4 peptide designed cloned tight
transcriptional control large metagenomic insert context (30 kb) serve as
proof-of-principle screening platform.
results: decrease parasite viability consistently correlated with
bioluminescence emitted parasite microcultures, exposure to
bacterial extracts containing plasmid fosmid engineered encode the
dermaseptin 4 anti-malarial peptide.
conclusions: here, new technical platform access anti-malarial potential
in microbial environmental metagenomes developed.

doi: 10.1186/s12936-015-0748-6 
pmcid: pmc4464701
pmid: 26040274  [indexed medline]

